$EQBK

EQUITY BANCSHARES INC (EQBK): December 31, 2025 and September 30, 2025 December 31, 2025 and September 30, 2025 Contents Consolidated Financial Statements

EQUITY BANCSHARES INC (EQBK) filed an SEC Form 8-K — Other Events. Exhibit 99.1 Frontier Holdings, LLC Consolidated Financial Statements December 31, 2025 and September 30, 2025 Frontier Holdings, LLC December 31, 2025 and September 30, 2025 Contents Consolidated Financial Statements Balance Sheets 1 Statements of Income 3 Statements of Comprehe

Original reporting
Published Oct 3, 2026, 1:50 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 10:05 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$EQBK
Bearish
high confidence
Mentioned
$EQBK
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$EQBKBearishMed
01

Why it matters

The disclosed net loss and modest revenue decline provide fresh data for valuation models.

02

Market read

First‑time release of quarterly loss for EQBK, likely prompting short‑term price adjustment.

03

What to watch

Liquidity remains solid and loan portfolio growth could support future earnings.

Relevance 6/10Novelty 7/10Timing: filed today

Background

Equity Bancshares Inc. (EQBK) filed an 8‑K reporting its interim consolidated financial statements for Q4 2025.

Company-level read

Ticker impact

$EQBKBearishHigh confidence
Context

SEC 8‑K filing provides unaudited interim statements showing a net loss of $891 k for the quarter ended Dec 31 2025.

Expected impact

likely downside as investors price in weaker earnings

Evidence & confidence

First‑time disclosure of a quarterly loss for a small‑cap bank typically triggers sell pressure.

Market effects

regional banking sector may see modest pullback

U.S. small‑cap financials could face slight weakness

limited to U.S. banking niche

Counterpoint

Loss may be temporary; balance sheet remains strong with $12.8 M cash.

Key entities

  • Equity Bancshares Inc.

    U.S. regional bank

Related articles

$EQBKMed

Equity Bancshares (EQBK) Q3 2026 Earnings Call Transcript

Equity Bancshares (EQBK) reported Q3 2026 earnings, highlighting organic growth with loans up $39M to $5.44B and deposits down $136M to $6.17B. The company announced a merger with Lincoln Bancorp, adding 16 branches in Iowa. Net income was $26.8M, or $1.29 per diluted share. The company expects margin to return to 4.25-4.35% in Q4, excluding the merger.

$EQBKMed

StoneX lowers Equity Bancshares stock price target on NIM outlook

StoneX reduced its price target for Equity Bancshares (EQBK) to $58 from $59, citing net interest margin expectations. The firm raised its fiscal 2026 EPS forecast to $5.18 but lowered the 2027 estimate to $5.27. EQBK's stock trades at a P/E ratio of 10.58, and analysts expect net income growth. The company recently reported Q3 earnings beating estimates, with EPS of $1.40 vs. $1.29 expected, but revenue missed slightly.

$EQBKMed

Equity Bancshares Q3 2026 slides: EPS beats amid margin pressure

Equity Bancshares (EQBK) reported Q3 2026 earnings of $1.40 per share, beating estimates, though revenue fell slightly short. The stock rose 0.99% to $47.03. The bank faces margin pressure but continues growth through acquisitions, including the pending Lincoln Savings Bank deal. Asset quality showed some deterioration, with nonperforming assets rising to 0.99%. The company is investing in AI to improve efficiency.

$EQBKMed

Equity Bancshares (EQBK) Posts Solid Net Interest Income Despite

Equity Bancshares (EQBK) reported Q2 2026 net interest income of $72.8M, down slightly from the prior quarter but up 16.6% year-over-year. The company's GF Value™ suggests it is modestly undervalued with a 15.2% margin of safety. EQBK has a GF Score™ of 81/100, indicating strong fundamentals in valuation and momentum, but weaker financial strength. Insiders and gurus have shown net selling activity. The stock trades at $46.57 with a trailing P/E of 27.97x and a forward P/E of 8.55x.